APULI MARICEL (Chief Accounting Officer) sold 1.5% of their position (2K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $143.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001470831-26-000410
Officer· Chief Accounting Officer
Since Feb 2026
-2K
Net shares
Net seller
$143.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$71.58
Trade value
$143.16K
% of position
1.5%
4/30/2026
136.12K→134.12K
Total
Net shares
−2K
Net value
-$143.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2026 | S · Sale | −2K | $71.58 | $143.16K | 1.5% | 136.12K | 134.12K |
| Total | −2K | -$143.16K | ||||||
Derivative Transactions0
No derivative transactions reported